Market intelligence
All coverage
SoFi’s stock has been on an explosive upward trajectory in 2025, recently soaring to all-time highs following its third-quarter earnings report. The share price…
Bitfarms’ stock has experienced an explosive rally in 2025. After starting the year near penny-stock levels, BITF climbed from under $1 in Q1 to…
Plug Power’s stock has been on a wild ride in 2025. After collapsing to penny-stock territory, PLUG staged a dramatic rally over the summer…
Dividend-focused ETFs have become go-to tools for investors seeking steady retirement income. By buying a single ETF, you get exposure to a basket of…
American taxpayers are poised for a record tax refund season in early 2026, with millions set to get substantially larger refunds when they file…
A wave of nostalgia hit Xbox fans when multiple Xbox 360 titles that had been delisted suddenly reappeared on the Microsoft Store in late…
Lam Research, a leading maker of semiconductor fabrication equipment, has been one of 2025’s standout stocks. The company’s share price has more than doubled…
Axsome’s stock has been a standout performer in 2025. As of November 3, 2025, AXSM trades around $134–$135 per share, roughly doubling from its…
ClearPoint Neuro’s stock has delivered dramatic gains in 2025, transforming from a little-known small-cap into a high-flyer. The share price rallied over 300% from…
Analyst outlook & forecast: Long-term, analysts model robust growth. For example, one financial model projects ~18% revenue CAGR: ~$3.3 billion in sales by 2028…
As of November 3, 2025, CURE Pharmaceutical’s stock is trading around $3.6 per share, reflecting an explosive rise in late October. On Friday, Oct…
Nocera is a small-cap company that began in the aquaculture technology niche. It designs and builds land-based recirculating aquaculture systems – essentially the tanks,…
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in treatments for B-cell mediated diseasesgurufocus.com. After years as a development-stage biotech, TG entered the…
Dominion Energy turned in strong third-quarter 2025 results, surpassing analyst expectations on the bottom line. The utility reported net income of $1.0 billion for…
In summary, Biohaven’s stock is a tale of high stakes in biotech. Recent price swings underscore the uncertainty, but also the potential reward if…
Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their…
